Facebook
X
LinkedIn
Forward
Project ECHO® Continuous Glucose Monitoring (CGM) in Gestational Diabetes: A Focus in South Dakota Online Activity
Continuous glucose monitoring (CGM) has demonstrated clear benefits in improving maternal and neonatal outcomes among individuals with gestational diabetes. Yet, adoption remains limited across clinical settings—particularly in multidisciplinary and interprofessional care environments.
Many obstetric, endocrinology, and primary care teams lack standardized workflows, shared protocols, and clear communication pathways for integrating CGM data into routine prenatal care. In addition. nurses, diabetes educators, dietitians, and care coordinators often receive minimal training or lack access to CGM interpretation tools, limiting their ability to collaborate effectively in patient management.
Importantly, South Dakota Medicaid has taken steps to expand access to CGM and now includes CGM on formulary for use in gestational diabetes, creating a timely opportunity for clinicians and care teams to integrate CGM into routine prenatal care.
This enduring activity is a recording of a Project ECHO® session, which took place in February 2026. Join us to learn how to optimize CGM implementation, ensure equitable access across diverse populations, and translate technology-driven insights into coordinated, patient-centered care.
Key Reasons to Participate
- Learn practical strategies to collaborate with multidisciplinary and interprofessional care teams in supporting pregnant patients using CGM
- Build confidence in CGM implementation and interpretation in your practice
- Discover South Dakota Medicaid policies, eligibility criteria, and procedures related to CGM coverage in gestational diabetes
Project ECHO®, developed in 2003 by the University of New Mexico, is a virtual knowledge and best-practice-sharing model that connects expert multidisciplinary and interprofessional teams with community-based clinicians, often from rural or underserved areas, through videoconferencing. Sessions include a didactic presentation and a learner presented deidentified case-based discussion, fostering peer-to-peer learning and mentorship. This “all teach, all learn” approach promotes continuous learning and collaboration, empowering clinicians to implement best practices and improve healthcare delivery in their communities, with long-lasting impacts that extend beyond traditional training methods.
This activity is supported by an educational grant from the Center for Health Care Strategies (CHCS) through the CGM Access Accelerator, an initiative led by CHCS through support from The Leona M. and Harry B. Helmsley Charitable Trust.
Target Audience
All members of primary care and OB/GYN teams in South Dakota and neighboring states in all practice settings including physicians, physician associates, advanced practice nurses, nurses, dietitians, diabetes educators (CDCES), and pharmacists.
Learning Objectives
- Describe the clinical benefits and evidence supporting continuous glucose monitoring (CGM) for improving maternal glycemic control, pregnancy outcomes, and patient engagement in gestational diabetes management.
- Explain the basic steps for CGM initiation and data review
- Locate trusted resources and tools to continue building confidence in CGM implementation and interpretation in your practice.
- Use effective communication and interdisciplinary and interprofessional collaboration to educate and support pregnant patients using CGM, reinforcing patient engagement, adherence, and care coordination.
- Apply best practices for incorporating CGM into clinical workflows.
- Explain South Dakota Medicaid policies, eligibility criteria, and procedures related to CGM coverage in gestational diabetes, and identify practical strategies to facilitate access for patients with SD Medicaid.
Additional Information
| Attachment | Size |
|---|---|
 Learning Resource.pdf | 266.67 KB |
Time | Topic | Speakers |
7 Minutes | Welcome, Polling and Introductions | Nicolas Cuttriss, MD, MPH, FAAP |
14 Minutes | The Role of Continuous Glucose Monitoring in Optimizing Pregnancy Outcomes in Gestational Diabetes (GDM) | Marina Basina, MD |
5 Minutes | Presentation Q&A | Questions submitted by participants |
5 Minutes | Case Presentation | Dalton Baird, MD |
22 Minutes | Case Questions and Recommendations | Hub team faculty & participants |
1 Minute | Wrap-up, Announcements, and Claiming Credit | Nicolas Cuttriss, MD, MPH, FAAP |
HIPAA | All patient information will be de-identified during the ECHO session | |
Featured Speaker
Marina Basina, MD
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Stanford University School of Medicine
Medical Director of Inpatient Diabetes
Stanford Hospital and Clinics
Stanford, CA
Featured Hub Panel
Clarissa Barnes, MD, MBA, FACP
Chief Medical Officer Medicaid
Department of Social Services Division of Medical Services
Sioux Falls, SD
Nicolas Cuttriss, MD, MPH, FAAP
Founding Director, CEO
ECHO Diabetes Action Network
Anchorage, AK
Melissa M. Belec, DO, MPH, DACD
Diabetes Institute at Touro University CA
Vallejo, CA
Frankie Benson, MS, RDN, LN
Patient, Registered Dietitian
David Faldmo, MPAS, PA-C, CHCEF
Chief Population Health Officer,
Siouxland Community Health Center (SCHC)
Sioux City, IA
Nancy Haugen, MSN, CNP, PCMH CCE
Area Diabetes & Nutrition Consultant
Great Plains Area Indian Health Service
Aberdeen, SD
Kimberlee McKay, MD, FACOG
Clinical Vice President OB/GYN Service Line
Avera Health
Sioux Falls, SD
Jay Shubrook, DO, FACOFP, FAAFP
Professor, Diabetologist
Touro University California
College of Osteopathic Medicine
Vallejo, CA
Kat Thomsen, MS, MPH, RDN
Clinical Dietician
Avera Queen of Peace Hospital and Avera Cancer Institute
Mitchell, SD
Deidra Van Gilder, PharmD
Professor and Interim Department Head
South Dakota State University, College of Pharmacy and Allied Health Professions
Brookings, SD
Clinical Pharmacist
Prairie Lakes Brown Clinic
Watertown, SD
Planner Disclosure
Linda G. Baer, MSPH, CHCP, Chief Operating Officer, ECHO Diabetes Action Network has no relevant financial relationships to disclose.
Accreditor Disclosures
The following planning committee members from Boston University Chobanian & Avedisian School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships to disclose:
Michael Burk, BS – Operations Manager
Accreditor Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
Off-Label Discussion
The faculty members do not plan on discussing the unlabeled/investigational use of any commercial products.
Disclaimer
THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
This activity is developed as a joint collaboration among ECHO Diabetes Action Network, South Dakota Medicaid, and Boston University Chobanian & Avedisian School of Medicine.
In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and ECHO Diabetes Action Network. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Accreditation
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Accreditation
The AAFP has reviewed Project ECHO® Continuous Glucose Monitoring (CGM) in Gestational Diabetes: A Focus in South Dakota and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credit(s). Term of Approval is from 03/25/2026 to 03/24/2027. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Pharmacist Accreditation
This activity is approved for 1.0 CPE credit.
UAN: JA0000185-0000-26-035-H01-P
Nurse Accreditation
Nursing Contact Hours: 1.0 contact hour
Physician Associate Accreditation
Boston University Chobanian & Avedisian School of Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.
Available Credit
- 1.00 AAFP Prescribed
- 1.00 AAPA Category I CME
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC
- 1.00 Participation
To Claim Credit:
Note that you will need to create an account if you do not already have one.
Click Register/Take Course, and then register or log in.
If you do not have an account with us, you will need to register and create a new account.
Once you’ve logged in, follow the steps below to claim your credit
- Click on “Take Course” and your enrollment will be recorded
- On the left, you’ll see a Course Progress bar; click on Pretest and Start to take complete the questions.
- Click on “Contentt” in the Course Progress bar on the left to review the video presentation. Click Start
- After the video, please complete the Posttest. You will be required to score 60% as a passing grade in order to claim credit.
- Complete the Evaluation questionnaire.
- Choose your credit and click submit
- Click on “Next” in the Course Navigation bar (bottom of screen)
- Download your certificate